Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination ...

Boston Mayor Michelle Wu delivered her annual State of the City address Wednesday night ... that drives innovation—where the scientists at Vertex invented life-changing non-opioid relief ...

for the hotel and hospitality workers who drive Boston’s tourism industry, one job is enough. We are a city that drives innovation — where the scientists at Vertex invented life-changing non ...

Boston Family Office LLC purchased ... Receive News & Ratings for Vertex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Boston Mayor Michelle Wu presented her third annual State of the City address on Wednesday evening ... drives innovation—where the scientists at Vertex invented life-changing non-opioid relief ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), based in Boston, specializes in developing ... like CRISPR/Cas9 and stem ...

Jan Treuren, SFT Product Lead, Cboe Clear Europe, said: "Clearing the first trades is an important milestone for our SFT services, and demonstrates our ability to efficiently leverage our ...

Ontrak, Inc , a leading AI-powered and telehealth-enabled behavioral healthcare company today announced that a new affiliated practice association has secured official Medicaid designation in two new ...

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (VRTX) (Nasdaq: VRTX) will report its first quarter 2025 financial results on Monday, May 5, 2025 after the financial markets close.